![Jeffrey Sevigny](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Sevigny
Directeur Technique/Scientifique/R&D chez
RAPPORT THERAPEUTICS, INC.
Fortune : - $ au 30/06/2026
Profil
Dr. Jeffrey Sevigny, MD, is a Chief Medical Officer at Rapport Therapeutics, Inc. Dr. Sevigny was previously employed as a Senior Vice President-Neuroscience by Eli Lilly & Co., an Independent Director by Acumen Pharmaceuticals, Inc., a Chief Medical Officer by Prevail Therapeutics, Inc., a Senior Director-Clinical Development by Biogen, Inc., an Assistant Professor by Albert Einstein College of Medicine, Inc., a Chairman-Research Roundtable by Alzheimer’s Association, an Assistant Professor by Columbia University College of Physicians & Surgeons, and a Vice President & Head-Translational Medicine by F.
Hoffmann-La Roche Ltd. He received his undergraduate degree from Bowdoin College and a doctorate degree from Tufts University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Jeffrey Sevigny
| Sociétés | Poste | Début |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 03/03/2025 |
Anciens postes connus de Jeffrey Sevigny
| Sociétés | Poste | Fin |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 02/01/2025 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 02/01/2025 |
| ACUMEN PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 12/08/2022 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2016 |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services Noncommercial Research Organizations | Corporate Officer/Principal | - |
Formation de Jeffrey Sevigny
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services Noncommercial Research Organizations | Commercial Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
